Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma.

Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma.
复制标题

正常和癌症成纤维细胞在皮肤T细胞淋巴瘤中差异调节Twist1,Tox和细胞因子基因表达。

DOI:
10.1186/s12885-021-08142-7
复制
发表时间:
2021-05-03
期刊:
影响因子:
3.8
通讯作者:
Wong HK
Wong HK
中科院分区:
医学2区
文献类型:
--
作者:
Mehdi SJ;Moerman-Herzog A;Wong HK

文献摘要

参考文献

被引文献

相似文献

蕈样肉芽肿 (MF) 是一种原发性皮肤 T 细胞淋巴瘤 (CTCL),由成熟的皮肤归巢 T 细胞转化,并在皮肤的早期阶段进展。皮肤微环境在 MF 发展中的作用尚不清楚,但最近在多种癌症中的发现强调了基质成纤维细胞在促进或抑制肿瘤发生中的作用。基质成纤维细胞是 MF 皮肤肿瘤微环境 (TME) 的重要组成部分。在这里,我们描述了对 TME 成纤维细胞和恶性 T 细胞相互作用的研究,以深入了解它们在 CTCL 中的作用。通过免疫组织化学分析正常 (n = 3) 和 MF 患者 (n = 3) 皮肤的 FAPα。 MyLa 是一种 CTCL 细胞系,保留了 CTCL 患者中经常检测到的生物标志物 TWIST1 和 TOX 的表达。在正常或 MF 皮肤来源的成纤维细胞存在或不存在的情况下,将 MyLa 细胞培养 5 天,用胰蛋白酶处理分离的 MyL a 细胞,并通过 RT-PCR 分析 MF 生物标志物(TWIST1 和 TOX)、Th1 标志物(IFNG、TBX21)、Th2 标志物(GATA3、IL16)和增殖标志物(MKI67)的基因表达。检测纯化的成纤维细胞的 VIM 和 ACTA2 基因表达。进行细胞衰老测定来评估衰老。与正常情况相比,MF 皮肤成纤维细胞的 FAP-α 表达随着阶段的增加而增加。与 MyLa 细胞共培养的正常成纤维细胞抑制 TWIST1 (p < 0.0006)、TOX (p < 0.03)、GATA3 (p < 0.02) 和 IL16 (p < 0.03) 的表达,并增加 IFNG (p < 0.03) 和MyLa 细胞中的 TBX21 (p< 0.03)。相比之下,与 MF 成纤维细胞一起培养的 MyLa 细胞保留了 TWIST1、TOX 和 GATA3 的高表达。 MF成纤维细胞与MyLa细胞共培养增加了MyLa细胞中IL16 (p<0.01)和IL4 (p<0.02)的表达,并抑制了IFNG和TBX21。此外,与 MF 成纤维细胞相比,正常成纤维细胞抑制 MyLa 细胞中 MKI67 的表达。皮肤成纤维细胞是 MF 中 TME 的重要组成部分。在共培养模型中,正常和 MF 成纤维细胞在调节 Th1 细胞因子和 CTCL 生物标志物基因的表达方面对 T 细胞表型具有不同的影响,揭示了在 MF 进展中的不同作用。在线版本包含可在 10.1186/s12885-021-08142-7 获取的补充材料。
Mycosis fungoides (MF) is a primary cutaneous T-cell lymphoma (CTCL) that transforms from mature, skin-homing T cells and progresses during the early stages in the skin. The role of the skin microenvironment in MF development is unclear, but recent findings in a variety of cancers have highlighted the role of stromal fibroblasts in promoting or inhibiting tumorigenesis. Stromal fibroblasts are an important part of the cutaneous tumor microenvironment (TME) in MF. Here we describe studies into the interaction of TME-fibroblasts and malignant T cells to gain insight into their role in CTCL. Skin from normal (n = 3) and MF patients (n = 3) were analyzed for FAPα by immunohistochemistry. MyLa is a CTCL cell line that retains expression of biomarkers TWIST1 and TOX that are frequently detected in CTCL patients. MyLa cells were cultured in the presence or absence of normal or MF skin derived fibroblasts for 5 days, trypsinized to detached MyL a cells, and gene expression analyzed by RT-PCR for MF biomarkers (TWIST1 and TOX), Th1 markers (IFNG, TBX21), Th2 markers (GATA3, IL16), and proliferation marker (MKI67). Purified fibroblasts were assayed for VIM and ACTA2 gene expression. Cellular senescence assay was performed to assess senescence. MF skin fibroblast showed increased expression of FAP-α with increasing stage compared to normal. Normal fibroblasts co-cultured with MyLa cells suppressed expression of TWIST1 (p < 0.0006), and TOX (p < 0.03), GATA3 (p < 0.02) and IL16 (p < 0.03), and increased expression of IFNG (p < 0.03) and TBX21 (p < 0.03) in MyLa cells. In contrast, MyLa cells cultured with MF fibroblasts retained high expression of TWIST1, TOX and GATA3. MF fibroblasts co-culture with MyLa cells increased expression of IL16 (p < 0.01) and IL4 (p < 0.02), and suppressed IFNG and TBX21 in MyLa cells. Furthermore, expression of MKI67 in MyLa cells was suppressed by normal fibroblasts compared to MF fibroblasts. Skin fibroblasts represent important components of the TME in MF. In co-culture model, normal and MF fibroblasts have differential influence on T-cell phenotype in modulating expression of Th1 cytokine and CTCL biomarker genes to reveal distinct roles with implications in MF progression. The online version contains supplementary material available at 10.1186/s12885-021-08142-7.
DOI: 10.1182/blood.v92.1.252.413k08_252_258
发表时间: 1998-07-01
期刊: BLOOD
影响因子: 20.3
作者:
Döbbeling, U;Dummer, R;Burg, G
通讯作者: Burg, G
来自恶性细胞的Th2细胞因子抑制了Th1反应并在白血病皮肤T细胞淋巴瘤中抑制全球Th2偏置。
DOI: 10.1158/1078-0432.ccr-12-3488
发表时间: 2013-07-15
期刊: Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子: --
作者:
Guenova E;Watanabe R;Teague JE;Desimone JA;Jiang Y;Dowlatshahi M;Schlapbach C;Schaekel K;Rook AH;Tawa M;Fisher DC;Kupper TS;Clark RA
通讯作者: Clark RA
DOI: 10.1038/s41586-019-1325-x
发表时间: 2019-07-11
期刊: NATURE
影响因子: 64.8
作者:
Khan, Omar;Giles, Josephine R.;Wherry, E. John
通讯作者: Wherry, E. John
DOI: 10.18632/oncotarget.2031
发表时间: 2014-06-30
期刊: Oncotarget
影响因子: --
作者:
Huang Y;Litvinov IV;Wang Y;Su MW;Tu P;Jiang X;Kupper TS;Dutz JP;Sasseville D;Zhou Y
通讯作者: Zhou Y
DOI: 10.1007/pl00007454
发表时间: 2000-01-01
影响因子: 3
作者:
Harwix, S;Zachmann, K;Neumann, C
通讯作者: Neumann, C